1
|
Darge H, Addisu KD, Tsai HC, Birhan YS, Hanurry EY, Mekonnen TW, Gebrie HT, Arunagiri V, Thankachan D, Wu TY, Lai JY, Chang HM, Huang CC, Wu SY. Actively Targeting Redox-Responsive Multifunctional Micelles for Synergistic Chemotherapy of Cancer. ACS OMEGA 2024; 9:34268-34280. [PMID: 39157138 PMCID: PMC11325410 DOI: 10.1021/acsomega.3c09817] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/08/2023] [Revised: 05/08/2024] [Accepted: 05/16/2024] [Indexed: 08/20/2024]
Abstract
Stimuli-responsive polymeric micelles decorated with cancer biomarkers represent an optimal choice for drug delivery applications due to their ability to enhance therapeutic efficacy while mitigating adverse side effects. Accordingly, we synthesized a digoxin-modified novel multifunctional redox-responsive disulfide-linked poly(ethylene glycol-b-poly(lactic-co-glycolic acid) copolymer (Bi(Dig-PEG-PLGA)-S2) for the targeted and controlled release of doxorubicin (DOX) in cancer cells. Within the micellar aggregate, the disulfide bond confers redox responsiveness, while the presence of the digoxin moiety acts as a targeting agent and chemosensitizer for DOX. Upon self-assembly in aqueous solution, Bi(Dig-PEG-PLGA)-S2 formed uniformly distributed spherical micelles with a hydrodynamic diameter (D h ) of 58.36 ± 0.78 nm and a zeta potential of -24.71 ± 1.01 mV. The micelles exhibited desirable serum and colloidal stability with a substantial drug loading capacity (DLC) of 6.26% and an encapsulation efficiency (EE) of 83.23%. In addition, the release of DOX demonstrated the redox-responsive behavior of the micelles, with approximately 89.41 ± 6.09 and 79.64 ± 6.68% of DOX diffusing from DOX@Bi(Dig-PEG-PLGA)-S2 in the presence of 10 mM GSH and 0.1 mM H2O2, respectively, over 96 h. Therefore, in HeLa cell lines, DOX@Bi(Dig-PEG-PLGA)-S2 showed enhanced intracellular accumulation and subsequent apoptotic effects, attributed to the targeting ability and chemosensitization potential of digoxin. Hence, these findings underscore the promising characteristics of Bi(Dig-PEG-PLGA)-S2 as a multifunctional drug delivery vehicle for cancer treatment.
Collapse
Affiliation(s)
- Haile
Fentahun Darge
- Graduate
Institute of Applied Science and Technology, National Taiwan University of Science and Technology, Taipei 10607, Taiwan
- College
of Medicine and Health Science, Bahir Dar
University, P.O. Box
79, Bahir Dar 00000, Ethiopia
- Centre
for Ocular Research & Education (CORE), School of Optometry and
Vision Science, University of Waterloo, 200 Columbia St W., Waterloo N2L 3W8, Canada
| | - Kefyalew Dagnew Addisu
- Graduate
Institute of Applied Science and Technology, National Taiwan University of Science and Technology, Taipei 10607, Taiwan
- Institute
of Technology, Bahir Dar University, P.O. Box 79, Bahir Dar 00000, Ethiopia
| | - Hsieh-Chih Tsai
- Graduate
Institute of Applied Science and Technology, National Taiwan University of Science and Technology, Taipei 10607, Taiwan
- Advanced
Membrane Materials Center, National Taiwan
University of Science and Technology, Taipei 10607, Taiwan
- R&D
Center
for Membrane Technology, Chung Yuan University, Chung-Li 320, Taiwan
| | - Yihenew Simegniew Birhan
- Graduate
Institute of Applied Science and Technology, National Taiwan University of Science and Technology, Taipei 10607, Taiwan
- Department
of Chemistry, College of Natural and Computational Sciences, Debre Markos University, P.O. Box 269, Debre Markos 00000, Ethiopia
| | - Endris Yibru Hanurry
- Graduate
Institute of Applied Science and Technology, National Taiwan University of Science and Technology, Taipei 10607, Taiwan
- School
of Medicine, Health Science College, Addis
Ababa University, P.O.
Box 1176, Addis Ababa 00000, Ethiopia
| | - Tefera Worku Mekonnen
- Graduate
Institute of Applied Science and Technology, National Taiwan University of Science and Technology, Taipei 10607, Taiwan
| | - Hailemichael Tegenu Gebrie
- Graduate
Institute of Applied Science and Technology, National Taiwan University of Science and Technology, Taipei 10607, Taiwan
| | - Vinothini Arunagiri
- Graduate
Institute of Applied Science and Technology, National Taiwan University of Science and Technology, Taipei 10607, Taiwan
| | - Darieo Thankachan
- Graduate
Institute of Applied Science and Technology, National Taiwan University of Science and Technology, Taipei 10607, Taiwan
| | - Tsung-Yun Wu
- Graduate
Institute of Applied Science and Technology, National Taiwan University of Science and Technology, Taipei 10607, Taiwan
| | - Juin-Yih Lai
- Graduate
Institute of Applied Science and Technology, National Taiwan University of Science and Technology, Taipei 10607, Taiwan
- Advanced
Membrane Materials Center, National Taiwan
University of Science and Technology, Taipei 10607, Taiwan
- R&D
Center
for Membrane Technology, Chung Yuan University, Chung-Li 320, Taiwan
| | - Hao-Ming Chang
- Division
of General Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan
| | - Chun-Chiang Huang
- Taiwan
Instrument Research Institute, National
Applied Research Laboratories, Hsinchu 300, Taiwan
| | - Szu-Yuan Wu
- Department
of Food Nutrition and Health Biotechnology, College of Medical and
Health Science, Asia University, Taichung 413, Taiwan
- Big
Data Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan 256, Taiwan
- Division
of Radiation Oncology, Department of Medicine, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan 256, Taiwan
- Department
of Healthcare Administration, College of Medical and Health Science, Asia University, Taichung 413, Taiwan
- Cancer
Center, Lo-Hsu Medical Foundation, Lotung
Poh-Ai Hospital, Yilan 256, Taiwan
- Graduate
Institute of Business Administration, Fu
Jen Catholic University, Taipei 242, Taiwan
- Centers
for Regional Anesthesia and Pain Medicine, Taipei Municipal Wan Fang
Hospital, Taipei Medical University, Taipei 110, Taiwan
| |
Collapse
|
2
|
Smart Polymeric Micelles for Anticancer Hydrophobic Drugs. Cancers (Basel) 2022; 15:cancers15010004. [PMID: 36612002 PMCID: PMC9817890 DOI: 10.3390/cancers15010004] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2022] [Revised: 12/15/2022] [Accepted: 12/16/2022] [Indexed: 12/24/2022] Open
Abstract
Cancer has become one of the deadliest diseases in our society. Surgery accompanied by subsequent chemotherapy is the treatment most used to prolong or save the patient's life. Still, it carries secondary risks such as infections and thrombosis and causes cytotoxic effects in healthy tissues. Using nanocarriers such as smart polymer micelles is a promising alternative to avoid or minimize these problems. These nanostructured systems will be able to encapsulate hydrophilic and hydrophobic drugs through modified copolymers with various functional groups such as carboxyls, amines, hydroxyls, etc. The release of the drug occurs due to the structural degradation of these copolymers when they are subjected to endogenous (pH, redox reactions, and enzymatic activity) and exogenous (temperature, ultrasound, light, magnetic and electric field) stimuli. We did a systematic review of the efficacy of smart polymeric micelles as nanocarriers for anticancer drugs (doxorubicin, paclitaxel, docetaxel, lapatinib, cisplatin, adriamycin, and curcumin). For this reason, we evaluate the influence of the synthesis methods and the physicochemical properties of these systems that subsequently allow an effective encapsulation and release of the drug. On the other hand, we demonstrate how computational chemistry will enable us to guide and optimize the design of these micelles to carry out better experimental work.
Collapse
|
4
|
Yang F, Xu J, Fu M, Ji J, Chi L, Zhai G. Development of stimuli-responsive intelligent polymer micelles for the delivery of doxorubicin. J Drug Target 2020; 28:993-1011. [PMID: 32378974 DOI: 10.1080/1061186x.2020.1766474] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Doxorubicin is still used as a first-line drug in current therapeutics for numerous types of malignant tumours (including lymphoma, transplantable leukaemia and solid tumour). Nevertheless, to overcome the serious side effects like cardiotoxicity and myelosuppression caused by effective doses of doxorubicin remains as a world-class puzzle. In recent years, the usage of biocompatible polymeric nanomaterials to form an intelligently sensitive carrier for the targeted release in tumour microenvironment has attracted wide attention. These different intelligent polymeric micelles (PMs) could change the pharmacokinetics process of drugs or respond in the special microenvironment of tumour site to maximise the efficacy and reduce the toxicity of doxorubicin in other tissues and organs. Several intelligent PMs have already been in the clinical research stage and planned for market. Therefore, related research remains active, and the latest nanotechnology approaches for doxorubicin delivery are always in the spotlight. Centring on the model drugs doxorubicin, this review summarised the mechanisms of PMs, classified the polymers used in the application of doxorubicin delivery and discussed some interesting and imaginative smart PMs in recent years.
Collapse
Affiliation(s)
- Fan Yang
- Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Jinan, PR China
| | - Jiangkang Xu
- Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Jinan, PR China
| | - Manfei Fu
- Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Jinan, PR China
| | - Jianbo Ji
- Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Jinan, PR China
| | - Liqun Chi
- Department of Pharmacy, Haidian Maternal and Child Health Hospital of Beijing, Beijing, PR China
| | - Guangxi Zhai
- Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Jinan, PR China
| |
Collapse
|